- Home
- RDFN vs TLRY Comparison
RDFN vs TLRY Comparison
Compare RDFN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDFN
- TLRY
- Stock Information
- Founded
- RDFN 2002
- TLRY N/A
- Country
- RDFN United States
- TLRY Canada
- Employees
- RDFN N/A
- TLRY N/A
- Industry
- RDFN Real Estate
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- RDFN Finance
- TLRY Health Care
- Exchange
- RDFN Nasdaq
- TLRY Nasdaq
- Market Cap
- RDFN 1.1B
- TLRY 1.1B
- IPO Year
- RDFN 2017
- TLRY 2018
- Fundamental
- Price
- RDFN $7.85
- TLRY $1.00
- Analyst Decision
- RDFN Hold
- TLRY Hold
- Analyst Count
- RDFN 11
- TLRY 3
- Target Price
- RDFN $9.43
- TLRY $1.88
- AVG Volume (30 Days)
- RDFN 4.4M
- TLRY 42.8M
- Earning Date
- RDFN 02-25-2025
- TLRY 01-10-2025
- Dividend Yield
- RDFN N/A
- TLRY N/A
- EPS Growth
- RDFN N/A
- TLRY N/A
- EPS
- RDFN N/A
- TLRY N/A
- Revenue
- RDFN $1,016,774,000.00
- TLRY $829,216,000.00
- Revenue This Year
- RDFN $8.63
- TLRY $15.63
- Revenue Next Year
- RDFN $9.90
- TLRY $5.63
- P/E Ratio
- RDFN N/A
- TLRY N/A
- Revenue Growth
- RDFN 3.70
- TLRY 18.38
- 52 Week Low
- RDFN $5.10
- TLRY $0.97
- 52 Week High
- RDFN $15.29
- TLRY $2.97
- Technical
- Relative Strength Index (RSI)
- RDFN 44.93
- TLRY 33.14
- Support Level
- RDFN $7.58
- TLRY $1.03
- Resistance Level
- RDFN $8.78
- TLRY $1.15
- Average True Range (ATR)
- RDFN 0.46
- TLRY 0.06
- MACD
- RDFN 0.06
- TLRY -0.01
- Stochastic Oscillator
- RDFN 22.50
- TLRY 7.16
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.